Sean Brynjelsen insider trades

Open-market stock purchases and sales by Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 4, 2016.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +270%.

Recent trades

DateStockTradeValue
May 28, 2026ETON Eton Pharmaceuticals, IncSold$3.8M
May 28, 2026ETON Eton Pharmaceuticals, IncSold$4.8K
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 1, 2026ETON Eton Pharmaceuticals, IncSold (not open market)$77.2K
Dec 12, 2025ETON Eton Pharmaceuticals, IncSold (not open market)$113K

Companies traded

  • ETON Eton Pharmaceuticals, Inc: 7 buys, 7 sales, last May 28, 2026
  • SGNT Sagent Pharmaceuticals, Inc: other filings, last Aug 29, 2016

Get free alerts when Sean Brynjelsen files a new trade →